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Abstract
Most of the cationic lipids used for gene transfer experiments drastically lose their efficiency in the presence of serum.
We used a cationic lipid with a spermine head group and its fluorescent analog to study the cellular uptake and the
intracellular fate of lipoplexes in the presence and absence of serum. We found that the amount of DNA and lipid taken up
by the cells was not related to the efficacy of the gene transfer. When the lipofection was performed in the presence of
serum, lipoplexes were contained within small intracellular vesicles. In the absence of serum, the vesicles were larger and
heterogeneous in size and shape. By analysis of their size distribution, we showed that lipoplexes preformed in the absence
of serum tended to aggregate. This aggregation was inhibited in the presence of serum. We used a carbonate formulation
that led to the preformation of large particles: those large particles gave a high lipofection efficiency in the presence of
serum and their intracellular distribution was identical to that observed in the absence of serum. q 1998 Elsevier Science
B.V.
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1. Introduction
There is growing evidence that gene therapy will
play a role in the future for the treatment of genetic
w xdisorders and acquired diseases 1 . However, in or-
der for gene therapy to be effective, it is necessary to
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium;
DOPE, dioleoyl phosphatidylethanolamine; FBS, fetal bovine
serum; lipofection, cationic lipid-mediated transfection;
lipoplexes, cationic lipidrDNA complexes; MEM, minimum es-
sential medium; PBS, phosphate-buffered saline, pH 7.4
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develop vectors that transport and introduce DNA
into the target cells, leading to the expression of the
therapeutic gene. Practically, an ideal gene delivery
vector should have the following characteristics: pro-
tecting and delivering DNA efficiently; non-toxic and
non-immunogenic; and easy to produce in large quan-
tities.
Compared with viral transfection systems, cationic
lipids represent one of the few examples that can
w xmeet these requirements 2 . For this reason, cationic
lipids have been used to transfect cells both in in
 w x.vitro and in vivo experiments reviewed in 3 . Sev-
eral formulations containing cationic lipid are being
w xused in clinical trials in cases of cystic fibrosis 4 or
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xcancer 5 .
Formulation of DNA with cationic lipids, often in
combination with a neutral phospholipid such as di-
 .oleoyl phosphatidylethanolamine DOPE , results in
w xcondensed particles, termed as lipoplexes 6 , formed
by ionic interaction between the cationic lipid and
negatively charged DNA and subsequent hydropho-
w xbic interactions between the lipid moieties 7 . The
DNA in these formulations is protected from the
environment and exhibits increased resistance to nu-
w xcleases 8–10 . By condensing the DNA and generat-
ing a particle with specific properties size, charge
.surface characteristics , cationic lipids may also cause
the particle to interact with the surface of the cell and
induce its uptake. A net positive charge, and there-
fore a cationic lipid excess, has been observed for
optimal in vitro lipofection efficiency, likely because
of the net negative charge exhibited by the plasma
w xmembrane 8,11,12 . Although much attention has
been focused on elucidating the mechanism by which
the DNA is introduced into the cells, a common and
generally accepted mechanism has not been identi-
fied. Most of the authors suggest that intracellular
w xdelivery of the DNA occurs via endocytosis 13–15 ,
whereas others tend to believe that fusion events at
the plasma membrane are involved in the uptake of
w x w xDNA 16 . Phagocytosis, pinocytosis 17 or pore
w xformation mechanism 8 have also been proposed to
account for the internalization process of lipoplexes.
Membrane-associated proteoglycans could mediate
w xthe binding and delivery of lipoplexes into cells 18 .
The effectiveness of gene delivery in vivo is poorly
w xpredicted by in vitro results 19 because the various
biological barriers and the interaction of lipoplexes
with blood elements are not reflected in in vitro
systems. For instance, many formulations leading to
efficient in vitro gene transfer in the absence of
serum are not effective in systems that contain as low
w xas 5–10% serum 12,20,21 , an observation that has
obvious shortcomings for potential in vivo applica-
tions.
We have synthesized a series of cationic lipids
bearing a spermine head group, a lipophilic tail and,
for one of them, a side chain harboring a rhodamine
w xmoiety 22,23 which displays a good lipofection
efficiency of cultured cells, in the absence or pres-
ence of serum. However, in some conditions of for-
mulation, the lipofection efficiency of these cationic
lipids was much lower in serum-containing medium.
In this paper, these transfecting agents were used in
these serum-sensitive conditions for studying the cel-
lular uptake of lipoplexes and their intracellular fate
when lipofection was performed in the presence or
absence of serum. Our results suggest that the main
effect of serum is to interact with preformed
lipoplexes, leading to a modification of their intra-
cellular traffic.
2. Materials and methods
2.1. Cell culture
Two fibroblast cell lines were used: CV-1, derived
from African green monkey kidney, and NIH 3T3
derived from NIH Swiss mouse embryo cultures. The
CV-1 cell line was obtained from Dr. S. Koutouzov
 .INSERM U25, Paris . NIH 3T3 cells were obtained
from the American Type Culture Collection. The
cells were grown in Minimum Essential Medium
 .MEM, Gibco for CV-1, or Dulbecco’s modified
 .Eagle’s medium DMEM, Gibco containing 4.5 grl
glucose for NIH 3T3, supplemented with 2 mM glu-
tamine, penicillinrstreptomycin 100 Urml and
.  .100 mgrml, respectively , and 10% vrv FBS. Cul-
tures were maintained at 378C in a 5% CO rair2
incubator.
2.2. Plasmids
Plasmid pCMVLuc carries a cassette containing
the enhancer–promoter from the immediate-early
 .gene of cytomegalovirus CMV , the gene coding for
the luciferase of Photinus pyralis and the polyadeny-
w xlation site of SV40 24 . Plasmid was grown using
standard techniques and was purified using Wizard
 .Megaprep kit Promega according to the supplier’s
recommendations. Radiolabeled plasmid was pre-
35 pared by random priming using S-dATPaS )1000
.Cirmmol, Amersham and Random Primed DNA
 .Labeling Kit Boehringer, Mannheim, Germany .
Fluorescent labeled plasmid was prepared by nick
w xtranslation 25 . Two nmol of FluoroRed Rhodamine
 .4-dUTP Amersham were incorporated into 30 mg of
plasmid DNA by nick translation using 100 pg of
 .DNase I Appligene Oncor , 20 U of DNA Poly-
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 .merase I Appligene Oncor and 60 nmol of dATP,
dCTP and dGTP, for 2 h at 168C, in 50 mM Tris HCl,
pH 7.5, 10 mM MgCl , 0.1 mM DTT and 50 mgrml2
Bovine Serum Albumin. Unincorporated nucleotides
were separated by spin column chromatography Mi-
.croSpin S-400 HR, Pharmacia . Nick translation was
optimized to produce plasmid DNA modification at
one fluorescent residue in 1000 base pairs.
2.3. Cationic lipids preparation and lipoplexes for-
mation
The lipopolyamines used in this study, RPR 120535
and RPR 121653, were synthesized and characterized
w xas described 22,23 . Stock solutions were prepared
by dissolving lyophilized cationic lipids in distilled
water at 25 mM. Cationic lipids were mixed and
diluted in 150 mM NaCl, or in 150 mM NaClr20 mM
NaHCO . The plasmid pCMVLuc encoding the lu-3
ciferase gene was diluted in 150 mM NaCl or in
150 mM NaClr20 mM NaHCO , and mixed with an3
equal volume of the cationic lipids solution. At this
stage, the RPR 120535 and RPR 121653 concentra-
tions were 60 and 10 mM respectively, and the plas-
mid concentration was 10 mgrml. These conditions
corresponded to a theoretical charge ratio of 9.0,
taking into account four possible positive charges on
the cationic lipids. The final DNArcationic lipids
mixture was vortexed, left for 10 min at room temper-
 .ature, diluted in culture medium DMEM or MEM
in the absence or presence of 10% FBS and then
added to the cells.
For lipofections using extracted plasmid, the same
procedure was used except for the following modifi-
cations: after quantification of total DNA using Pico-
TM green dsDNA quantitation reagent Molecular
.Probes , the extracted plasmid was mixed with a
carrier DNA, namely a plasmid without luciferase
gene, diluted in 150 mM NaCl before mixing with an
equal volume of RPR 120535. The lipofection was
performed in the following conditions: 1 mg of DNA
 .carrier DNAq total extracted DNA and 6 nmol of
 .RPR 120535 per culture well charge ratio of 7.7 ,
diluted in serum-free medium.
2.4. Lipofection
The day before the experiment, NIH 3T3 cells
were seeded into 6-well culture plates on the basis of
200 000 cells per well. Just before lipofection, cells
were washed twice with fresh medium with or with-
out FBS. The lipoplexes solution prepared as de-
 .scribed above Section 2.3 was added to the cells
6 nmol of RPR 120535, 1 nmol of RPR 121653 and
1mg of plasmid per well, corresponding to a charge
.  .ratio of 9.0 . 10% vrv of FBS was added to the
culture wells containing serum-free lipofection
medium after 2 h at 378C. The cells were incubated
for 24 h at 378C in the presence of 5% CO . CV-12
were transfected with the same procedure, except that
they were seeded two days before the experiment on
the basis of 100 000 cells per well.
2.5. Luciferase assay
The transfected cells were washed twice with PBS,
and lysed with 200 ml cell culture lysis reagent Pro-
.mega . Luciferase expression was quantified on 5ml
of centrifuged lysate supernatant, using a luciferase
 .assay kit Promega . Light emission was measured by
integration over 10 s at 258C using a Lumat LB9501
 .luminometer EG and G, Berthold, Evry, France .
 .Relative light units RLU were calculated versus
background activity. Light emission was normalized
to the protein concentration of each sample, deter-
 .mined using the Pierce BCA assay Interchim .
2.6. Plasmid extraction and quantification
The transfected cells were trypsinized and washed
once with PBS. Selective plasmid extraction was
w xperformed according to Hirt’s protocol 26 with the
following modifications: cells were resuspended in
buffer A 25 mM Tris-HCl, pH 8; 10 mM EDTA,
. 50 mM glucose , then lysed with buffer B 0.2 M
.NaOH, 1% SDS . Most of the cellular DNA and
proteins were removed by adding buffer C 3 M
.potassium acetate, pH 4.8; 2 M acetic acid and cen-
trifugation at 14 000 g for 10 min at room tempera-
ture. A volume ratio of 1r2r1.5 was used for the
 .three buffers ArBrC, respectively . After a phe-
nolrchloroform extraction step, plasmid was then
concentrated by ethanol precipitation and resus-
pended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA.
The amount of extracted plasmid was then quantified
by dot-blot analysis. The sample to analyze was
heated at 1008C for 10 min then chilled on ice, and
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TM  .applied onto a Hybond -N membrane Amersham
prewetted with 10=SSC 1.5 M NaCl, 0.15 M Na3
.citrate . The membrane was placed for 5 min in dena-
 .turing solution 1.5 M NaCl, 0.5 M NaOH then for
1 min in neutralizing solution 1.5 M NaCl, 0.5 M
.Tris-HCl, pH 7.2; 1 mM EDTA . The DNA was
linked to the membrane by baking in an oven at 808C
for 2 h. The membrane was prehybridized using pre-
 .hybridization solution GIBCO containing 6=SSC,
 .5 = Denhardt’s solution, 0.5% wrv SDS,
100 mgrml sheared, denatured salmon sperm DNA,
for 1 h at 658C, and hybridized overnight at 658C
with 0.2 pmol of 35S-labeled plasmid DNA. After
several washes, the membrane was cut and radioac-
tivity was counted by liquid scintillation. Serial dilu-
tions of pCMVLuc in supernatants of non-transfected
cells were used to generate a calibration curve with a
linear regression coefficient higher than 0.98. The
amount of extracted plasmid was determined by com-
parison with this calibration curve. Treatment of the
plasmid by DNase I completely abolished the signal.
2.7. Cationic lipid quantification
RPR 121653 is a derivative of RPR 120535, which
bears a covalently linked rhodamine moiety. It can
therefore be easily quantified by measuring its fluo-
rescence emission. The transfected cells were washed
twice with PBS, and lysed with 200 ml cell culture
 .lysis reagent Promega . A 100 ml-aliquot of the cen-
trifuged supernatant lysate was used to measure fluo-
 .rescence emission at 590 nm excitation 544 nm in a
Titertekw Fluoroskan II. The amount of cationic lipid
RPR 121653 contained in the lysate, referred to as the
amount of internalized cationic lipid, was determined
by comparison with the fluorescent signal obtained
with serial dilutions of known amounts of the cationic
lipid in the same buffer.
2.8. Fluorescence microscopy
Cells were seeded on glass slides and transfected
as indicated above. After 24 h, cells were rinsed three
 .times with PBS, then fixed for 20 min in 3% wrv
paraformaldehyde in PBS, washed, and mounted in
Mowiol for examination. Slides were then analyzed
with a Zeiss Axiophot microscope equipped with a
Zeiss Neofluar 100 X objective lens.
2.9. Size distribution of lipoplexes
The size distribution of the lipoplexes was deter-
mined by dynamic light scattering in a Coulter N4
Plus particle analyzer. Unimodal fit yielded the mean
hydrodynamic particle diameter. Samples were pre-
 .pared as described above Section 2.3 , except that
solutions were ten-fold more concentrated in order to
obtain a signal in light scattering. The size distribu-
tion of the complexes was assayed in the initial
incubation medium 150 mM NaCl or 150 mM NaCl
.plus 20 mM NaHCO after 10 min or 2 h of incuba-3
tion, or after dilution of the preformed complexes in
serum-free or serum-containing DMEM and subse-
quent incubation for 10 min or 2 h.
3. Results
Most of the cationic lipids currently used for in
vitro gene transfer are much less efficient in the
w xpresence of serum 12,20,21 . We synthesized a
cationic lipid with a spermine head group, referred to
w xas RPR 120535 22 . Preparation and characterization
of this cationic lipid, as well as its lipofection effi-
w xciency, have been described elsewhere 22,23,27 . It
was shown that RPR 120535 has a high lipofection
efficiency, both in vitro in the presence and absence
of serum, and in vivo. However, in some conditions
of formulation, the lipofection efficiency of
RPR 120535 is reduced in the presence of serum. In
this work, we have used two fibroblastic cell lines,
NIH 3T3 and CV-1, with different lipofection abili-
ties: NIH 3T3 are known to be readily transfectable
by cationic lipids, while CV-1 cells display a lower
lipofection capacity. These cells were transfected for
2 h with RPR 120535rpCMVLuc complexes in the
presence or absence of serum, followed by 24 h of
incubation in the presence of serum. Lipofection was
performed in serum-sensitive conditions of formula-
tion, namely preformation of lipoplexes in 150 mM
NaCl, at a charge ratio of 9.0. As shown in Fig. 1, the
luciferase activity was 100-fold higher in the serum-
free medium in both cell lines. We first asked whether
this decrease of lipofection efficiency originated from
a decreased uptake of lipoplexes by cells as a result
of the presence of the serum in the medium.
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Fig. 1. Lipofection by lipopolyamine RPR 120535 in the presence or absence of serum. NIH 3T3 and CV-1 cells were transfected for 2 h
 .with pCMVLuc complexed with RPR 120535 6 nmol of cationic lipid per mg of plasmid, theoretical charge ratio of 7.7 in the absence or
presence of 10% FBS. 10% of FBS was added in the culture wells containing lipofection medium without FBS after 2 h at 378C. The cells
 .were then incubated for 24 h before assay of luciferase expression. Values represent means"SD ns6 .
Fig. 2. Uptake of lipoplexes in the presence or absence of serum. NIH 3T3 and CV-1 were transfected for 2 h with pCMVLuc complexed
 .with cationic lipids 6 nmol of RPR 120535 and 1 nmol of RPR 121653 per mg of plasmid; theoretical charge ratio of 9.0 in the absence
or presence of 10% FBS. 10% of FBS was added in culture wells containing lipofection medium without FBS after 2 h at 378C. The cells
 .  .were then incubated for 24 h before assay of DNA uptake dot-blot and cationic lipid uptake fluorescence as described in Section 2.
 .Values represent means"SD ns4 . The difference in the amount of DNA uptake between the two conditions of lipofection was
 .significant for both cell lines p-0.05 .
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3.1. Uptake of lipoplexes
We quantified the amount of plasmid DNA and
cationic lipid recovered in transfected cells 24 h after
lipofection. We took advantage of a covalently rho-
damine-labeled cationic lipid, analog to RPR 120535,
referred to as RPR 121653, to assay the amount of
internalized cationic lipid. As indicated in Fig. 2, for
both cell lines, there was no sharp difference in the
amount of internalized cationic lipid in the presence
or absence of serum. The ratio of internalized cationic
lipid to the initial amount used for lipofection was
around 12% and 20% for CV-1 and NIH 3T3 cells,
respectively. We used dot-blot analysis of clear lysate
supernatants to estimate the amount of internalized
plasmid. In the absence of serum, CV-1 and NIH 3T3
cells took up respectively 14% and 25% of the initial
amount of plasmid DNA used for the lipofection. In
the presence of serum, cells internalized two to three
times less plasmid than in the absence of serum Fig.
.2 . We therefore concluded that serum has little or no
effect on the uptake of the lipoplexes.
3.2. Effect of the serum on degradation or inacti˝a-
tion of the transfected plasmid
Serum is known to exhibit an intrinsic DNase
w xactivity 9,28 . We first examined by agarose gel
electrophoresis the plasmid extracted from the trans-
fected cells and purified by phenolrchloroform ex-
traction followed by ethanol precipitation. As shown
in Fig. 3, the majority of the extracted plasmid was in
a supercoiled or a relaxed form, whether the lipofec-
tion was performed in the presence or absence of
serum. It was verified by a restriction analysis and
comparison with the native plasmid, that the two
DNA bands, the supercoiled and relaxed forms, actu-
ally corresponded to the plasmid pCMVLuc data not
.shown . In the presence of serum however, the amount
of supercoiled and relaxed plasmid was decreased.
Neither linear plasmid nor fragments were visible. An
additional band, which migrated between the relaxed
and the supercoiled form of the plasmid, was also
present in the negative controls and most probably
originated from genomic DNA extracted from the
cells.
We next examined whether the extracted plasmid
was still functional for lipofection. The plasmid ex-
tracted from transfected NIH 3T3 cells in the pres-
ence or absence of serum was used to transfect NIH
3T3 cells again. Since the amount of extracted plas-
mid was low, it was diluted with a carrier DNA
before mixing with RPR 120535 and incubation with
NIH 3T3 cells, in order to obtain properly formed
lipoplexes. The luciferase activity obtained was com-
Fig. 3. Agarose gel electrophoresis analysis of plasmid extracted from transfected cells. DNA was extracted from CV-1 cells transfected
 .  .  .with pCMVLuc complexed with RPR 120535 in the presence 3 or absence 4 of FBS, or from non transfected cells in the presence 1
 .or absence 2 of FBS. Electrophoresis was done on 0.8% agarose gel and DNA was stained with ethidium bromide. L: molecular weight
 .  .marker for linear DNA fragments 1kb-ladder ; Sp: molecular weight marker for supercoiled DNA fragments 1kb-ladder .
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Table 1
Quantification of plasmid DNA extracted from transfected cells
a  .Conditions of the first lipofection Amount of extracted pCMVLuc ng assayed by
Dot-blot analysis Lipofection activity
q10% FBS 7.5 11.6
yFBS 17.0 15.7
b b .Control without plasmid n.d. n.d.
a After 24 h-lipofection of NIH 3T3 in the presence or absence of serum, the plasmid was extracted from transfected cells. The amount of
extracted plasmid was quantified either by dot-blot analysis or by measurement of the lipofection activity of NIH 3T3 cells as described
in Section 2. The results are from one experiment that was a representative of one out of 3 experiments.
b
n.dsnon detectable.
pared with the luciferase expression obtained with
known amounts of native pCMVLuc diluted in car-
rier DNA. These serial dilutions of pCMVLuc gave a
linear relationship between the luciferase activity and
the amount of DNA regression coefficient higher
.than 0.98, data not shown . The amount of plasmid
DNA calculated from the lipofection experiment was
compared with the amount quantified by dot-blot
analysis. As indicated in Table 1, the extracted plas-
mid has retained its functional integrity, whether the
lipofection was performed in the presence or absence
of serum. Moreover, the results obtained with the two
methods were coherent. This indicates that the amount
of plasmid DNA quantified by dot-blot corresponds
to active plasmid DNA.
3.3. Modification of the intracellular traffic of
lipoplexes by serum
We next investigated whether the serum has an
effect on the intracellular pathway of the lipoplexes.
The intracellular localization of the lipoplexes was
analyzed by fluorescent microscopy, using the fluo-
rescent cationic lipid RPR 121653 or a fluorescent
nick-translated plasmid. It was observed that
RPR 121653 was able to transfect both NIH 3T3 and
CV-1 cells and that its lipofection efficiency was
 .decreased by serum data not shown . We found that
plasmid DNA and cationic lipid were present in
100% of the cells, displaying a punctuate cytoplasmic
 .staining, mostly in the perinuclear region Fig. 4 .
However, a clear difference was observed depending
on whether the serum was present or not, both in NIH
3T3 and CV-1 cells. When the lipofection was per-
formed in a serum-free medium, the labeled cationic
lipid appeared to be contained within vesicles that
seemed very heterogeneous in size and shape Fig.
 .  ..4 B and D . In the presence of serum, labeled
  .vesicles were smaller and homogenous Fig. 4 A and
 ..C . The same pattern of fluorescence and the same
difference in the presence or absence of serum were
observed in cells transfected with RPR 120535 and a
  .  ..fluorescently labeled plasmid Fig. 4 E and F .
When we exposed cells to fluorescently labeled dex-
tran, a polymer which is endocytosed and delivered
to the lysosomal compartment, we found a similar
pattern of fluorescence as these observed with cells
transfected in the presence of serum, i.e. small and
 .homogenous intracellular vesicles data not shown .
3.4. Modification of the size of the lipoplexes by
serum
Since the main difference observed between the
two conditions of lipofection was the size of the
vesicles that contained the lipoplexes, we decided to
Fig. 4. Fluorescence microscopy of NIH 3T3 and CV-1 cells transfected with fluorescent cationic lipid or DNA. Cells were transfected
 .  .for 2 h in the presence Panels A, C, E and G or absence Panels B, D, F of serum as described in the legend of Fig. 2, except that cells
were seeded on slides. After 24 h of incubation, cells were fixed and mounted for observation. Panels A and B: NIH 3T3 cells transfected
with labeled cationic lipid, panels C and D: CV-1 cells transfected with labeled cationic lipid. Panels E and F: CV-1 cells transfected with
nick-translated plasmid. Panel G: CV-1 cells transfected with serum-insensitive particles complexes of labeled cationic lipid and DNA
.preformed in the presence of NaHCO .3
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Table 2
Size distribution of RPR 120535rRPR 121653rpCMVLuc complexes
Conditions of incubation 10 min 120 min
 .Mean diameter"SD nm
NaCl 135"45 165"61
 .NaCl 10 min then DMEMq10% FBS 532"193 673"239
 .NaCl 10 min then DMEMyFBS 818"365 1340"603
NaClrNaHCO 1717"775 2903"11313
 .NaClrNaHCO 10 min then DMEM q10% FBS 540"218 1130"5353
 .Dilutions were prepared as described for the lipoplexes formation protocol see Section 2.3 , except that solutions were ten-fold more
concentrated in order to obtain a signal in light scattering. The size distribution of the complexes was assayed in the initial incubation
 .medium 150 mM NaCl or 150 mM NaCl plus 20 mM NaHCO after 10 min or 2 h of incubation, or after dilution of the preformed3
complexes in serum-free or serum-containing medium and subsequent incubation for 10 min, or 2 h.
investigate the effect of serum on the size of the
lipoplexes before incubation with cells. The size dis-
tribution of the lipoplexes was determined by dy-
namic light scattering. The assay was first performed
in NaCl 150 mM medium used for the initial forma-
.tion of the lipoplexes . As indicated in Table 2, rather
small and stable particles were obtained in the 100–
200 nm diameter range. When these preformed small
particles were diluted in DMEM, their size increased.
In serum-containing DMEM, the particles reached a
size of 500 nm that remained relatively stable up to
2 h. In contrast, in serum-free DMEM, after 2 h of
incubation, particles were twice larger than in the
presence of serum.
3.5. Formation of lipoplexes insensiti˝e to the pres-
ence of serum
Our results when taken together suggested that the
 .larger particles )1 mm observed in serum-free
DMEM, were more efficient for the lipofection of
cultured cells than the smaller ones. The aggregating
potency of DMEM could be attributed to its content
in sodium bicarbonate, since 20 mM NaHCO was3
 .able to lead to large lipoplexes by itself Table 2 .
We then examined the lipofection of CV-1 and NIH
3T3 cells with these large particles, preformed in
sodium bicarbonate, in the presence of serum: as
shown in Table 3, the luciferase expression was of
the same level as that obtained with particles, pre-
formed in NaCl, in the absence of serum. The amount
of plasmid DNA and cationic lipid taken up by the
 .cells was similar in all conditions tested Table 3 .
When the intracellular traffic of these serum-insensi-
tive particles, preformed in sodium bicarbonate, was
followed, the internalized labeled cationic lipid was
localized within vesicles that seemed very heteroge-
neous in size and shape, as observed above for
lipofection with particles preformed in NaCl and
  ..diluted in serum-free medium Fig. 4 G .
Table 3
Luciferase expression and uptake of lipoplexes in the presence or absence of serum
Conditions of complex formation NaCl NaClrNaHCO3
Conditions of lipofection DMEMyFBS DMEMq10% FBS DMEMq10% FBS
6 .Luciferase activity NIH 3T3 =10 2.6"1.3 0.1"0.1 2.0"1.5
4 .  .RLUrmg protein CV-1 =10 1.5"0.8 0.02"0.02 1.8"0.7
Internalized RPR 121653 NIH 3T3 1.03"0.42 0.70"0.30 0.64"0.14
 .pmolrmg protein CV-1 1.57"0.24 1.29"0.43 1.60"0.38
Internalized pCMVLuc plasmid NIH 3T3 1.76"0.39 0.61"0.33 0.71"0.38
 .ng DNArmg protein CV-1 1.76"0.83 0.68"0.38 2.05"1.07
NIH 3T3 and CV-1 cells were transfected for 2 h with pCMVLuc complexed with cationic lipids 6 nmol of RPR 120535 and 1 nmol of
.RPR 121653 per mg of plasmid; theoretical charge ratio of 9 in the absence or presence of 10% FBS. Lipoplexes were preformed in
150 mM NaCl or in 150 mM NaClr20 mM NaHCO , then diluted in DMEM with or without FBS. 10% of FBS was added in culture3
wells containing lipofection medium without FBS after 2 h at 378C. The cells were then incubated for 24 h before assay of DNA uptake,
 .  .cationic lipid uptake and luciferase expression as described in Section 2 . Values represent means"SD ns4 .
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4. Discussion
Cationic lipids are now widely used as effective
w xtools for delivering DNA into mammalian cells 3 .
Yet little is known about the mechanism that governs
cationic lipid mediated DNA uptake. While it seems
clear that a transient membrane destabilization event
must occur, the detailed mechanism of this event and
its cellular localization, namely at the plasma mem-
brane or at the endosomal membrane, are still de-
w xbated questions 13,14,16,17 . Hence, the processes
which result in the intracellular DNA delivery might
vary depending not only on the compound and for-
mulation tested, but also on the cell type. The ability
of the serum to inhibit lipofection is an often de-
w xscribed phenomenon 12,20,21 . We therefore investi-
gated the mechanism underlying such an inhibitory
effect, that represents a major drawback of this non
viral method of gene transfer, especially in vivo.
First, we precisely quantified the amount of inter-
nalized plasmid by a dot-blot analysis of the clear
lysate obtained from transfected cells. A 2- to 3-fold
decrease in the amount of internalized plasmid was
found in the presence of serum. In the same way, we
analyzed the cationic lipid uptake and found no sig-
nificant difference between the two conditions of
lipofection. This was in sharp contrast with the two
log collapse in transgene expression. We then exam-
ined the effect of serum on the degradation of the
plasmid. When complexed with a cationic lipid, plas-
mid DNA exhibits increased resistance to nucleases
w x8,9 . However, besides nucleases, serum contains
various negatively charged proteins that could bind to
lipoplexes and modify their structural characteristics,
making DNA accessible to nucleases. If serum had a
pronounced DNA degradation effect, we expected
that neither circular nor functional plasmid DNA
could be extracted from cells transfected in the pres-
ence of serum. The purified plasmid DNA, extracted
from transfected cells, was analyzed by two different
methods. First, by gel electrophoresis analysis, we
detected only supercoiled and relaxed plasmid but no
linear DNA either in the absence or presence of
serum. Second, the amount of functional plasmid was
estimated from its capacity to transfect NIH 3T3
cells. It appeared that this extracted plasmid was still
functional and we only observed a difference in the
amount of extractable plasmid, between the two con-
ditions of lipofection. It must be noted that
phenolrchloroform extraction and ethanol precipita-
tion are not very reproducible methods. Nevertheless,
these results show that the plasmid recovered from
the cells and quantified by dot-blot analysis is a
functional, either supercoiled or relaxed plasmid. Our
results also suggest that plasmid DNA was probably
more degraded by nucleases in the presence of serum,
but this effect was not sufficient to account for the
hundred-fold decrease in transgene expression ob-
served.
We next investigated the intracellular pathway of
the lipoplexes. This has been previously studied with
fluorescent lipids that were mixed with the transfect-
w xing agent 16,21,29 . In the present work, we have
used a cationic lipid bearing a rhodamine moiety, that
ensured us that the fluorescent pattern we observed
corresponded to the cationic lipid. We made the
assumption that the intracellular particles observed
were lipoplexes-containing vesicles as suggested by
w xelectronic microscopy data 14,15 . We found a clear
difference in the intracellular traffic in cells trans-
fected in the presence or absence of serum. When the
lipofection was performed in the presence of serum,
the labeled cationic lipid was contained within small
vesicles that looked like endocytic vesicles. In the
absence of serum, cationic lipid containing vesicles
appeared larger and heterogeneous in size and shape.
The same observations were made while using a
fluorescent plasmid. The presence of large vesicles
has also been reported by Zabner et al. with com-
plexes which contained either isatoic ester-labeled
w  . x N- 1- 2,3-dimyristyloxy propyl -N, N-dimethyl-N- 2-
.  .hydroxyethyl ammonium bromide DMRIE or 4-
 .chloro-7-nitrobenzo-2-oxa-1,3-diazole NBD -labeled
w xDOPE 14 . These large particles may play an active
role in the internalization of DNA into the cell,
possibly by destabilizing the vesicles and releasing
the DNA or lipoplexes into the cytoplasm.
Lipopolyamines, unlike most cationic lipids, provide
effective in vitro gene transfer even in the absence of
a colipid, such as DOPE. It has been hypothesized
that the addition of the colipid leads to fusion be-
tween the lipids in the complex and the endosomal
membrane, destabilizing the endosome and releasing
w xthe DNA or lipoplexes into the body of the cell 30 .
The ability of lipopolyamines to give rise to large
intracellular vesicles might explain why they promote
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efficient gene transfer without formulation with a
colipid.
We next asked whether these large vesicles arose
from the fusion and coalescence of endosomes or
from the formation of large complexes prior to inter-
nalization. Analysis of the size distribution of the
lipoplexes by dynamic light scattering showed that
preformation of complexes between plasmid DNA
and RPR 120535 in 150 mM NaCl led to stable parti-
cles in the 100–200 nm range. This result is in agree-
ment with previous results concerning the structural
w xcharacteristics of these lipoplexes 27 . When these
preformed lipoplexes were diluted in culture medium
 .DMEM with or without serum , their size increased.
In the presence of serum, the complexes remained
relatively stable with diameter below 700 nm. On the
contrary, in a serum-free lipofection medium, parti-
cles increased in size and became very large diame-
.ter)1 mm . However, in this size range, dynamic
light scattering is no longer an accurate method to
determine size distribution. We therefore confirmed
our size measurements by examining our lipoplexes
using fluorescence microscopy and comparing them
with size-calibrating fluorescent latex beads Fluo-
w .Spheres , Molecular Probes . We observed that in
the absence of serum, lipoplexes were twice larger
 .than in the presence of serum data not shown .
These results indicate that lipoplexes preformed in
NaCl tend to aggregate when diluted in a culture
medium like DMEM. However, if serum is present in
the medium this aggregation is inhibited. According
to our results, large aggregated complexes are more
potent transfecting agents than small ones, which is
w xconsistent with other reports 31,32 . This assumption
is further substantiated by the serum-resistance of the
large cationic lipidrDNA particles formed in sodium
 .bicarbonate Table 3 .
The lipofection efficiency of lipoplexes could be
also related to their structure, as reported by
w xBoukhnikachvili et al. 33 . They compared the struc-
ture of various lipoplexes, composed of the liposper-
 .mine DOGS dioctadecylamidoglycyl-spermine , dis-
playing variable lipofection efficiencies in the pres-
ence of FBS. They showed that serum-sensitive
lipoplexes were micellar complexes whereas serum-
insensitive lipoplexes were of the lamellar type. In
the absence of serum, micellar complexes could be-
come lamellar and then efficient for gene transfer,
whereas in the presence of serum, this evolution
would be hindered. The interaction between
lipoplexes and serum is probably due to negatively
charged proteins present in the serum. The
cationicranionic charge ratio, which is an essential
parameter for efficient lipofection, is also probably
decisive for binding of serum components on
lipoplexes.
The ability of large complexes to mediate gene
transfer could question the involvement of endocyto-
sis in the uptake of the complexes in the absence of
serum. Indeed, both type of endocytosis, via coated
pit and non-coated pathways, are limited in the size
of the particle that can be taken up. Thus, particles
greater than 200 nm in diameter are not efficiently
taken up by the coated pit pathway. On the other
hand, fibroblasts are not phagocytic cells, but some
cultured cells have the capability to take up particles
w xof much larger size by a phagocytic process 17 . The
mechanism by which DNA is taken up by cells might
be multiple and vary with cell lines, formulation and
lipofection conditions used.
Lipofection studies which led to efficient in vitro
gene transfer in the presence of serum arose from
wimproved conditions of formulations 20–22,33–
x.35 : for instance, formation of lipoplexes in the
presence of detergent and subsequent removal of the
w xdetergent by dialysis 34 , precondensation of plasmid
DNA with polylysine before formation of the
w xlipoplexes 21 , or sequential addition of the lipid to
w xplasmid DNA 35 . These formulations have to be
tested in in vivo experiments to determine if they
offer a potential for their use in in vivo applications
of gene transfer. Actually, besides interaction with
w xserum proteins, interaction with complement 36 or
with polyanions, and low diffusibility through the
extracellular space are as many obstacles to a suc-
cessful in vivo gene transfer. Particularly, a low net
positive charge could be necessary for an easy diffu-
sion of lipoplexes within the extracellular compart-
ments. For instance, non viral gene transfer into the
newborn mouse brain was enhanced by using a low
w xcharge ratio for lipospermine lipoplexes 37 .
In conclusion, the structural characteristics of a
lipoplex interacting with the cell membrane might
particularly influence the way it will be taken up and
determine its intracellular fate. In the present work,
the comparison of serum-insensitive and serum-sensi-
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tive particles showed that the amount of DNA and
lipid taken up by the cells was not related to the
efficacy of gene transfer. We have also shown that, in
our conditions, gene transfer was more efficient when
cells took up large particles, leading to the formation
of large intracellular vesicles. These large vesicles
would be more easily disrupted, thus releasing DNA
into the cytoplasm. Strategies to overcome the entry
barrier represented by plasma membrane might re-
quire improvements of our knowledge in structural
characteristics and stability of the lipoplexes.
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